BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetic-hemodynamic studies of nitroglycerin in congestive cardiac failure. 1980

P W Armstrong, and J A Armstrong, and G S Marks

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P W Armstrong, and J A Armstrong, and G S Marks
Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
October 1976, The American journal of cardiology,
P W Armstrong, and J A Armstrong, and G S Marks
Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
April 1987, The American journal of cardiology,
P W Armstrong, and J A Armstrong, and G S Marks
Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
November 1985, American heart journal,
P W Armstrong, and J A Armstrong, and G S Marks
Buccal nitroglycerin in congestive cardiac failure: a multicentre study.
January 1986, The Journal of international medical research,
P W Armstrong, and J A Armstrong, and G S Marks
Buccal nitroglycerin in elderly patients with congestive cardiac failure.
December 1985, The Practitioner,
P W Armstrong, and J A Armstrong, and G S Marks
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
November 1980, Chest,
P W Armstrong, and J A Armstrong, and G S Marks
Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
August 1988, The American journal of cardiology,
P W Armstrong, and J A Armstrong, and G S Marks
Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
February 1986, The American journal of cardiology,
P W Armstrong, and J A Armstrong, and G S Marks
Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
July 1984, The American journal of cardiology,
P W Armstrong, and J A Armstrong, and G S Marks
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
September 1975, Circulation,
Copied contents to your clipboard!